MDWD MediWound, Ltd. Net Income

Corporate emblem and logo of mediwound.com (MDWD)

MediWound Ltd. (MDWD) specializes in developing innovative therapies for severe skin injuries, as evidenced by the share price chart, where the indicator stands at -0.02. The business operates within a niche segment, contending with pressure from global behemoths and traditional therapeutic approaches. The company's stability is ensured by experienced biotechnologists retained through a stock option system and an active search for marketing experts in the US.

Company Net Income: MediWound Ltd. (MDWD) for 07/04/2022 - 10/31/2026

Analytical breakdowns and data insights for company mediwound.com (MDWD)

- share price and expert price forecast:
Price MediWound|MDWD - Price Target Chart
- market capitalization data:
Market Valuation MediWound Ltd|MDWD - Enterprise Value
- company book value details:
Net Asset Value per Share MediWound Ltd.|MDWD - Company Book Value|Capitalization to Book Value Ratio mediwound.com|MDWD - Cumulative Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Capital MediWound Ltd.|MDWD - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio MediWound|MDWD - Company Aggregate Debts|Debts to Book Value MediWound Ltd|MDWD - Company Long-Term Debts|Company Short-Term Indebtedness MediWound Ltd.|Interim Coverage Ratio mediwound.com
- company profitability and valuation multiples indicators:
MDWD - Net Income
Fundamental valuation:MDWD MediWound, Ltd.
Flagship merchandise of MediWound Ltd

The elite status of NexoBrid and the trust of combustion specialists ensure MediWound Ltd. (MDWD) a steady stream of high-margin orders. This metric aggregates daily operational results, neutralizing the time lag associated with quarterly reporting. It captures net income dynamics, revealing hidden resource accumulation or a decline in business activity. The consolidation of this metric at peak levels confirms the model's resilience. Analyzing the company's total financial result allows for the timely identification of deep drawdown risks.

Direct competitors

HCA: Profit After Payment of Taxes|Company Net Income Tenet Healthcare|Net Income freseniusmedicalcare.com (FMS)|Net Profit SOLV|EHC - Company Net Income|Company Net Income Universal Health Services, Inc. UHS|DVA: Company Profit|RDNT: Net Income|optioncarehealth.com - Profit After Payment of Taxes|Surgery Partners (SGRY) - Company Net Income|Net Income Premier Inc|EYE (National Vision Corp) - Net Profit|Company Net Income Progyny Corp PGNY|Net Profit ARDT|selectmedical.com - Company Profit|Net Profit ASTH (Astrana Health)|Net Financial Result MEDNAX (MD)|USPH: Net Income|The Pennant Group Corp (PNTG) - Net Income|Organogenesis Holdings (ORGO) - Company Net Income|Company Net Income nutexhealth.com (NUTX)|Net Income AUNA|Net Profit SBC Medical Group Holdings|Company Net Income Jeuveau (EOLS)|Community Health Corp - Company Profit|Net Profit SKIN (BeautyHealth)|BTMD: Company Profit|JYNT: Net Income|Final Profit DCGO (DocGo, Inc.)|p3hp.org (PIII) - Company Net Income|GANX (Gain Therapeutics Inc.) - Company Net Income|Net Income EUDA|BMGL (Basel Medical Group Limited) - Profit After Payment of Taxes|Net Profit CLGN|Cuprina Holdings (Cayman) Ltd. - Company Profit|Concord Medical Services Holdings Limited - Net Income|Net Financial Result ASHS (AMS)|MRM - Company Net Income|Avalon GloboCare (ALBT) - Net Income|DHAI: Net Profit|Company Profit XAGE|Net Income NIVF|Net Income ATI Physical Therapy Corp (ATIP)|Net Profit CMAX|kindlymd.com - Company Profit|ModivCare - Net Income|Profit After Payment of Taxes NVOS (Novo Integrated Sciences Inc)|SSY - Company Net Income|Final Profit BACK (IMAC Corp)